Vaccination prevents severe COVID-19 outcome in patients with neutralizing type 1 interferon autoantibodies

Summary: A hallmark of patients with autoimmune polyendocrine syndrome type 1 (APS-1) is serological neutralizing autoantibodies against type 1 interferons (IFN-I). The presence of these antibodies has been associated with severe course of COVID-19. The aims of this study were to investigate SARS-Co...

पूर्ण विवरण

ग्रंथसूची विवरण

मुख्य लेखकों:	Anette S.B. Wolff, Lena Hansen, Marianne Aa. Grytaas, Bergithe E. Oftedal, Lars Breivik, Fan Zhou, Karl Ove Hufthammer, Thea Sjøgren, Jan Stefan Olofsson, Mai Chi Trieu, Anthony Meager, Anders P. Jørgensen, Kari Lima, Kristin Greve-Isdahl Mohn, Nina Langeland, Rebecca Jane Cox, Eystein S. Husebye
स्वरूप:	Artigo
भाषा:	Inglês
प्रकाशित:	Elsevier 2023-07-01
श्रृंखला:	iScience
विषय:	Health sciences Biological sciences Immunology Immune response
ऑनलाइन पहुंच:	http://www.sciencedirect.com/science/article/pii/S2589004223011616
टैग:	टैग जोड़ें कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!